These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31158457)

  • 1. Targeted quantitative proteomic analysis of drug metabolizing enzymes and transporters by nano LC-MS/MS in the sandwich cultured human hepatocyte model.
    Khatri R; Fallon JK; Rementer RJB; Kulick NT; Lee CR; Smith PC
    J Pharmacol Toxicol Methods; 2019; 98():106590. PubMed ID: 31158457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of pregnancy related hormones on drug metabolizing enzyme and transport protein concentrations in human hepatocytes.
    Fashe MM; Fallon JK; Miner TA; Tiley JB; Smith PC; Lee CR
    Front Pharmacol; 2022; 13():1004010. PubMed ID: 36210832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ontogeny of Small Intestinal Drug Transporters and Metabolizing Enzymes Based on Targeted Quantitative Proteomics.
    Kiss M; Mbasu R; Nicolaï J; Barnouin K; Kotian A; Mooij MG; Kist N; Wijnen RMH; Ungell AL; Cutler P; Russel FGM; de Wildt SN
    Drug Metab Dispos; 2021 Dec; 49(12):1038-1046. PubMed ID: 34548392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of constitutive androstane receptor in Toll-like receptor-mediated regulation of gene expression of hepatic drug-metabolizing enzymes and transporters.
    Shah P; Guo T; Moore DD; Ghose R
    Drug Metab Dispos; 2014 Jan; 42(1):172-81. PubMed ID: 24194512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absolute quantification and differential expression of drug transporters, cytochrome P450 enzymes, and UDP-glucuronosyltransferases in cultured primary human hepatocytes.
    Schaefer O; Ohtsuki S; Kawakami H; Inoue T; Liehner S; Saito A; Sakamoto A; Ishiguro N; Matsumaru T; Terasaki T; Ebner T
    Drug Metab Dispos; 2012 Jan; 40(1):93-103. PubMed ID: 21979928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a rapid and sensitive multiple reaction monitoring proteomic approach for quantification of transporters in human liver tissue.
    Wang L; Rubadue KJ; Alberts J; Bedwell DW; Ruterbories KJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1061-1062():356-363. PubMed ID: 28800539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translational value of liquid chromatography coupled with tandem mass spectrometry-based quantitative proteomics for in vitro-in vivo extrapolation of drug metabolism and transport and considerations in selecting appropriate techniques.
    Al Feteisi H; Achour B; Rostami-Hodjegan A; Barber J
    Expert Opin Drug Metab Toxicol; 2015; 11(9):1357-69. PubMed ID: 26108733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of membrane transporter proteins in human lung and immortalized cell lines using targeted quantitative proteomic analysis by isotope dilution nanoLC-MS/MS.
    Fallon JK; Houvig N; Booth-Genthe CL; Smith PC
    J Pharm Biomed Anal; 2018 May; 154():150-157. PubMed ID: 29544106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Proteomic Quantification Approaches for Hepatic Drug Transporters: Multiplexed Global Quantitation Correlates with Targeted Proteomic Quantitation.
    Vildhede A; Nguyen C; Erickson BK; Kunz RC; Jones R; Kimoto E; Bourbonais F; Rodrigues AD; Varma MVS
    Drug Metab Dispos; 2018 May; 46(5):692-696. PubMed ID: 29439128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of Four Efflux Drug Transporters in Liver and Kidney Across Species Using Targeted Quantitative Proteomics by Isotope Dilution NanoLC-MS/MS.
    Fallon JK; Smith PC; Xia CQ; Kim MS
    Pharm Res; 2016 Sep; 33(9):2280-8. PubMed ID: 27356525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic Modeling of Pitavastatin Disposition in Sandwich-Cultured Human Hepatocytes: A Proteomics-Informed Bottom-Up Approach.
    Vildhede A; Mateus A; Khan EK; Lai Y; Karlgren M; Artursson P; Kjellsson MC
    Drug Metab Dispos; 2016 Apr; 44(4):505-16. PubMed ID: 26842596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of phase I, II and III drug metabolism/transport by xenobiotics.
    Xu C; Li CY; Kong AN
    Arch Pharm Res; 2005 Mar; 28(3):249-68. PubMed ID: 15832810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comparison of Total and Plasma Membrane Abundance of Transporters in Suspended, Plated, Sandwich-Cultured Human Hepatocytes Versus Human Liver Tissue Using Quantitative Targeted Proteomics and Cell Surface Biotinylation.
    Kumar V; Salphati L; Hop CECA; Xiao G; Lai Y; Mathias A; Chu X; Humphreys WG; Liao M; Heyward S; Unadkat JD
    Drug Metab Dispos; 2019 Apr; 47(4):350-357. PubMed ID: 30622164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of Hepatic Organic Anion Transport Proteins OAT2 and OAT7 in Human Liver Tissue and Primary Hepatocytes.
    Vildhede A; Kimoto E; Rodrigues AD; Varma MVS
    Mol Pharm; 2018 Aug; 15(8):3227-3235. PubMed ID: 29906129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasensitive Quantification of Drug-metabolizing Enzymes and Transporters in Small Sample Volume by Microflow LC-MS/MS.
    Ahire DS; Basit A; Karasu M; Prasad B
    J Pharm Sci; 2021 Jul; 110(7):2833-2840. PubMed ID: 33785352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Localization and Functional Activity of the Main Hepatobiliary Transporters in HepaRG Cells and Primary Human Hepatocytes.
    Bachour-El Azzi P; Sharanek A; Burban A; Li R; Guével RL; Abdel-Razzak Z; Stieger B; Guguen-Guillouzo C; Guillouzo A
    Toxicol Sci; 2015 May; 145(1):157-68. PubMed ID: 25690737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved extrapolation of hepatobiliary clearance from in vitro sandwich cultured rat hepatocytes through absolute quantification of hepatobiliary transporters.
    Li N; Singh P; Mandrell KM; Lai Y
    Mol Pharm; 2010 Jun; 7(3):630-41. PubMed ID: 20438085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct Quantification of Cytochromes P450 and Drug Transporters-A Rapid, Targeted Mass Spectrometry-Based Immunoassay Panel for Tissues and Cell Culture Lysates.
    Weiß F; Hammer HS; Klein K; Planatscher H; Zanger UM; Norén A; Wegler C; Artursson P; Joos TO; Poetz O
    Drug Metab Dispos; 2018 Apr; 46(4):387-396. PubMed ID: 29343608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishing Transcriptional Signatures to Differentiate PXR-, CAR-, and AhR-Mediated Regulation of Drug Metabolism and Transport Genes in Cryopreserved Human Hepatocytes.
    Moscovitz JE; Kalgutkar AS; Nulick K; Johnson N; Lin Z; Goosen TC; Weng Y
    J Pharmacol Exp Ther; 2018 May; 365(2):262-271. PubMed ID: 29440451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of uPA/SCID mouse with humanized liver as a human liver model: protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases by LC-MS/MS.
    Ohtsuki S; Kawakami H; Inoue T; Nakamura K; Tateno C; Katsukura Y; Obuchi W; Uchida Y; Kamiie J; Horie T; Terasaki T
    Drug Metab Dispos; 2014 Jun; 42(6):1039-43. PubMed ID: 24711249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.